Treatment of Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis with Lenalidomide in a Patient Testing Negative for 5q Deletion and JAK2 V617F and MPL W515K/L Mutations

Refractory anemia with ring sideroblasts associated with marked thrombocytosis (RARS-T) is a hematologic malignancy that often results in transfusion dependency and a hypercoagulable state. This rare disease currently lacks formal guidelines for treatment; however, various case reports have demonstr...

Descripción completa

Detalles Bibliográficos
Autores principales: Keen, Ryan, Pantin, Jeremy, Savage, Natasha, Dainer, Paul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136742/
https://www.ncbi.nlm.nih.gov/pubmed/27994837
http://dx.doi.org/10.4081/hr.2016.6592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136742/
https://www.ncbi.nlm.nih.gov/pubmed/27994837
http://dx.doi.org/10.4081/hr.2016.6592

Ejemplares similares